As digital health technology continues to advance the healthcare ecosystem, many companies are seeking to develop software-as-a-medical-device (SaMD) products. SaMD classification is a major decision point for organizations, and preparing for that means understanding a costly, lengthy, controlled process, teeming with nuances and risks. In this webinar, ZS Associate Principal Dan Weinstein and Liquid Amber Lead Consultant Acacia Parks discuss the challenges faced by companies transitioning from non-SaMD to SaMD product development and strategies to overcome them.
This webinar covers:
- Potential benefits to transitioning a wellness software product to SaMD
- The hurdles to overcome in the transition
- Potential missteps and how to avoid them
Whether your company is already mid-development or just setting down its roadmap, we hope you’ll gain valuable insight as we share our industry knowledge on these exciting and important technologies—which we believe will shape the future of healthcare.